International Biotechnology Trust (IBT) is an established investor in the high-growth area of biotechnology. It is differentiated from peers by including unquoted companies (<10% of assets) alongside quoted holdings. The biotech sector seems largely to have shrugged off recent criticism over excessive pricing in some areas and long-term performance has been impressive, with the benchmark NASDAQ Biotech Index up 304% over five years compared with a return of 45% for the FTSE All-Share. IBT
11 Dec 2015
Dual portfolio drives recent outperformance
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Dual portfolio drives recent outperformance
International Biotechnology Trust PLC (IBT:LON) | 627 0 0.0% | Mkt Cap: 236.9m
- Published:
11 Dec 2015 - Author:
-
Pages:
8
International Biotechnology Trust (IBT) is an established investor in the high-growth area of biotechnology. It is differentiated from peers by including unquoted companies (<10% of assets) alongside quoted holdings. The biotech sector seems largely to have shrugged off recent criticism over excessive pricing in some areas and long-term performance has been impressive, with the benchmark NASDAQ Biotech Index up 304% over five years compared with a return of 45% for the FTSE All-Share. IBT